Certain embodiments of the present technology described herein relate to detecting atrial oversensing, characterizing atrial oversensing, determining when atrial oversensing is likely to occur, and or reducing the chance of atrial oversensing occurring. Some such embodiments characterize and/or avoid atrial oversensing.

Certain embodiments of the present technology described herein relate to detecting atrial oversensing, characterizing atrial oversensing, determining when atrial oversensing is likely to occur, and or reducing the chance of atrial oversensing occurring. Some such embodiments relate to specifying an atrial oversensing avoidance (AOA) period corresponding to when atrial oversensing may occur following one or more paced or sensed atrial events, and after specifying the AOA period selectively using an atrial oversensing avoidance technique during one or more instances of the AOA period that follow paced or sensed atrial events to thereby reduce a likelihood of atrial oversensing during the one or more instances of the AOA period.

A medical device is configured to sense a cardiac electrical signal and determine from the cardiac electrical signal at least one of a maximum peak amplitude of a positive slope of the cardiac electrical signal and a maximum peak time interval from a pacing pulse to the maximum peak amplitude. The device is configured to determine a capture type of the pacing pulse based on at least one or both of the maximum peak amplitude and the maximum peak time interval.

An implantable medical device for stimulating a heart, includes a stimulation electrode configured to stimulate a first cardiac region of the heart, and a detection unit configured to detect an intracardiac electrogram at a second cardiac region (ventricle) of the heart. In operation, the device: delivers a stimulation pulse to the heart; evaluates a time and at least one morphologic parameter of a responsive signal of an intracardiac electrogram, wherein the at least one morphologic parameter is chosen from: an absolute value of the signal amplitude, a width of the signal, a positive, negative and/or total area under at least a part of the signal, and a number of occurrences and/or time of occurrence of zero crossings of the signal; and identifies a dislocation of the stimulation electrode if the time of the signal is below a first threshold value and the morphologic parameter exceeds a further threshold value.

A leadless pacing device for implanting into an atrium of a heart. The leadless device comprises an implant anchor for connecting the device to an inner wall of the atrium; a stimulator for a direct stimulation of the atrium; a sensor for sensing a ventricular activity of the heart corresponding to the direct stimulation of the atrium. Further aspects relate to a system comprising such leadless pacing device, a method and a computer program that may be executed by such leadless pacing device.

A medical device is configured to sense a cardiac signal, determine a monitoring metric representative of activity of at least one heart chamber from the sensed cardiac signal, and determine that the monitoring metric meets expected rhythm criteria. The medical device may enable a monitoring feature of the medical device that is based on processing and analysis of the cardiac signal in response to the monitoring metric meeting the expected rhythm criteria.

Described herein are leadless pacemakers (LPs) and methods for use therewith. In certain embodiments an LP stores a polarization artifacts template or a capture plus polarization artifacts template in memory of the LP. The LP uses the stored template when performing autocapture and/or other types of capture detection to mitigate adverse effects of electrode polarization. Such embodiments are especially useful where the LP is an atrial LP, but can also be used to other types of LPs, such as a ventricular LP.